Mariner, LLC Mirum Pharmaceuticals, Inc. Transaction History
Mariner, LLC
- $58.8 Billion
- Q1 2025
A detailed history of Mariner, LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Mariner, LLC holds 4,464 shares of MIRM stock, worth $196,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,464Holding current value
$196,416% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
224Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$299 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$210 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$142 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$123 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$112 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.62B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...